[1]刘岸,艾超,唐婧,等.腹膜透析液联合尿毒清颗粒保留灌肠对CKD5期非透析患者肾功能及电解质的影响[J].西部中医药,2022,35(09):95-98.[doi:10.12174/j.issn.2096-9600.2022.09.18]
 LIU An,AI Chao,TANG Jing,et al.Influence of Peritoneal Dialysis Solution and Uremic Clearance Granules Retention Enema on Renal Function and Electrolyte in Non-dialysis Patients with 5 Stage CKD[J].Western Journal of Traditional Chinese Medicine,2022,35(09):95-98.[doi:10.12174/j.issn.2096-9600.2022.09.18]
点击复制

腹膜透析液联合尿毒清颗粒保留灌肠对CKD5期非透析患者肾功能及电解质的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年09期
页码:
95-98
栏目:
出版日期:
2022-09-15

文章信息/Info

Title:
Influence of Peritoneal Dialysis Solution and Uremic Clearance Granules Retention Enema on Renal Function and Electrolyte in Non-dialysis Patients with 5 Stage CKD
作者:
刘岸1,2, 艾超1,2, 唐婧1,2, 唐蕾1,2, 毛乾泰1,2, 安扬1,2
1.清华大学附属北京清华长庚医院,北京 102218
2.清华大学临床医学院
Author(s):
LIU An1,2, AI Chao1,2, TANG Jing1,2, TANG Lei1,2, MAO Qiantai1,2, AN Yang1,2
1.Beijing Tsinghua Changgung Hospital, Beijing 102218, China
2.School of Clinical Medicine, Tsinghua University
关键词:
慢性肾脏病5期非透析电解质肾功能腹膜透析液保留灌肠尿毒清颗粒
Keywords:
chronic kidney diseasenon-dialysis 5 stage CKDelectrolyterenal functionperitoneal dialysis solutionretention enemauremic clearance granules
分类号:
R256.51
DOI:
10.12174/j.issn.2096-9600.2022.09.18
摘要:
目的探讨腹膜透析液联合尿毒清颗粒保留灌肠对慢性肾脏病(chronic kidney disease,CKD)5期非透析患者肾功能及电解质的影响。 方法将肾小球滤过率(glomerular filtration rate,GFR)<15 mL/min的CKD 5期患者68例采用随机数字表法分为对照组及观察组各34例。两组均参照美国肾脏病基金会制定的肾脏病生存质量指导(kidney disease outcomes quality initiative,KDOQI)和改善全球肾脏病预后组织(kidney disease:improving global outcomes,KDIGO)指南给予西医基础治疗,对照组患者每天1.5%腹膜透析液1000 mL清洁灌肠,观察组先予1.5%腹膜透析液1000 mL清洁肠道,后用尿毒清颗粒2包加入生理盐水200 mL保留灌肠40 min。观察两组患者临床疗效、中医证候积分、肾功能及血清电解质[磷(P)、钾(K)]。 结果观察组总有效率为94.12%,高于对照组的76.47%(P<0.05)。治疗后两组患者5项中医证候积分均下降,观察组低于对照组(P<0.05)。治疗后两组患者肌酐(serum creatinine,SCr)、尿素氮(blood urea nitrogen,BUN)、尿酸(uric acid,UA)均下降(P<0.05),且观察组低于对照组(P<0.05);GFR均升高(P<0.05),观察组高于对照组(P<0.05)。治疗后观察组P、K水平低于对照组(P<0.05)。 结论腹膜透析液联合尿毒清颗粒保留灌肠对CKD 5期非透析患者病情控制具有积极作用,能改善电解质紊乱。
Abstract:
ObjectiveTo discuss the effects of peritoneal dialysis solution and uremic clearance granules retention enema on renal function and electrolyte in non-dialysis patients with stage 5 CKD. MethodsAll 68 patients with glomerular filtration rate (GFR)<15 mL/min were allocated to the control group and the observation group by using random number table method, with 34 cases in each group. Both groups accepted basic therapy of Western medicine by referring to KDOQI and KDIGO guideline, the control group accepted the cleansing enema of 1.5% peritoneal dialysis solution, 1000mL each day, while the observation group received bowel cleaning with 1000 mL of 1.5% peritoneal dialysis solution, and then retention enema for 40 minutes with 200 mL of normal saline and two packs of uremic clearance granules. To observe clinical effects, TCM syndrome scores, renal function and serum electrolytes [phosphorus (P) and potassium (K)] between both groups. ResultsTotal effective rate of the observation group was 94.12%, higher than 76.47% of the control group (P<0.05). After the treatment, five items of TCM syndrome scores reduced in both groups, the observation group was lower than the control group (P<0.05). After the treatment, SCr, BUN and UA in both groups decreased (P<0.05), the observation group was lower than the control group (P<0.05); GFR increased (P<0.05), the observation group was higher than the control group (P<0.05). After the treatment, the levels of P and K of the observation group were lower than these of the control group (P<0.05). ConclusionPeritoneal dialysis solution and uremic clearance granules retention enema have positive effects on controlling the disease conditions in patients, which could correct electrolyte disturbance.

相似文献/References:

[1]俞徽,张茹,李桂霞,等.许筠主任医师祛瘀通络法结合象思维治疗慢性肾脏病经验[J].西部中医药,2017,30(11):64.
 YU Hui,ZHANG Ru,LI Guixia,et al.Chief Physician Xu Jun′s Experience of Treating Chronic Kidney Disease by Stasis-eliminating Collaterals-dredging Method Combined with Image Thinking[J].Western Journal of Traditional Chinese Medicine,2017,30(09):64.
[2]陈翀,孙伟△.基于肠肾轴概念从肾-肺-大肠轴谈孙伟教授治疗慢性肾脏病的经验[J].西部中医药,2019,32(05):74.
 CHEN Chong,SUN Wei.Professor Sun Wei′s Experience of Treating Chronic Kidney Disease from the Axis of Kidney-Lung-Large Intestine Based on the Concept of Gut-kidney Axis[J].Western Journal of Traditional Chinese Medicine,2019,32(09):74.
[3]宋玉,姜晨.中药干预CKD血管钙化的研究进展[J].西部中医药,2020,33(03):150.[doi:10.12174/j.issn.1004-6852.2020.03.43]
 SONG Yu,JIANG Chen.Research Progress on Materia Medica in the Intervention of CKD Vascular Calcification[J].Western Journal of Traditional Chinese Medicine,2020,33(09):150.[doi:10.12174/j.issn.1004-6852.2020.03.43]
[4]曾翠青,吴东明,段小军,等.足三里穴位注射重组人促红素治疗肾性贫血疗效观察[J].西部中医药,2022,35(09):126.[doi:10.12174/j.issn.2096-9600.2022.09.26]
 ZENG Cuiqing,WU Dongming,DUAN Xiaojun,et al.Clinical Observation on Zusanli Acupoint Injection of Recombinant Human Erythropoietin Injection in the Treatment of Renal Anemia[J].Western Journal of Traditional Chinese Medicine,2022,35(09):126.[doi:10.12174/j.issn.2096-9600.2022.09.26]
[5]金文,陈潇颖,郭立中.基于“肾-脾-大肠轴”理论探讨针药联合治疗慢性肾脏病合并腹泻经验[J].西部中医药,2023,36(03):135.[doi:10.12174/j.issn.2096-9600.2023.03.27]
 JIN Wen,CHEN Xiaoying,GUO Lizhong.The Experience of Treating Chronic Kidney Disease and Diarrhea with the Combination of Acupuncture and Medicine Based on "Kidney-Spleen-Intestine Axis" Theory[J].Western Journal of Traditional Chinese Medicine,2023,36(09):135.[doi:10.12174/j.issn.2096-9600.2023.03.27]
[6]李姗姗,孙倩,杨少宁,等.HIF-1α对慢性肾脏病血管钙化作用的相关研究进展[J].西部中医药,2024,37(01):106.[doi:10.12174/j.issn.2096-9600.2024.01.21]
 LI Shanshan,SUN Qian,YANG Shaoning,et al.Research Progress of the Effect of HIF-1α on Vascular Calcification in Chronic Kidney Disease[J].Western Journal of Traditional Chinese Medicine,2024,37(09):106.[doi:10.12174/j.issn.2096-9600.2024.01.21]
[7]李炯汾,黄雪霞,龙萍,等.健脾益肾汤对慢性肾脏病4期患者肾功能及肠道菌群的影响[J].西部中医药,2024,37(01):120.[doi:10.12174/j.issn.2096-9600.2024.01.23]
 LI Jiongfen,HUANG Xuexia,LONG Ping,et al.Effect of Invigorating-spleen Benefiting-kidney Decoction on Renal Function and Intestinal Flora of Patients with Stage Ⅳ Chronic Kidney Disease[J].Western Journal of Traditional Chinese Medicine,2024,37(09):120.[doi:10.12174/j.issn.2096-9600.2024.01.23]

备注/Memo

备注/Memo:
刘岸(1988—),女,主管药师,研究方向:临床药学。北京市自然科学基金(重点研究专题项目)(京020170103)。
更新日期/Last Update: 2022-10-08